Preparation and evaluation of formalized bivalent Newcastle and Salmonella poultry vaccine

This study was conducted to prepare and evaluate the potency of different inactivated vaccine formulations that protect chickens against Salmonella Enteritidis and Newcastle disease virus using Montanide as adjuvant. Protection and the humoral immune response of prepared vaccines against Salmonella Enteritidis and Newcastle disease virus was evaluated and compared to imported vaccine. In this study, different formulae of Salmonella Enteritidis and Newcastle disease vaccines were prepared and compared with the imported one by measuring the antibody titer against Newcastle disease virus by hemagglutination inhibition test and the antibody titer against Salmonella Enteritidis using Enzyme Linked Immunosorbent Assay. On the other hand, the protection percentages against Newcastle disease and Salmonella Enteritidis were recorded to determine the best effective formula. The highest hemagglutination inhibition antibody level against NDV at first week was recorded for the prepared combined Newcastle disease and Salmonella Enteritidis vaccine (4.2 log2) followed by the prepared monovalent Newcastle disease (3.4 log2); the lowest antibody level (3.1 log2) was obtained with the imported vaccine. A gradual increase was observed in all groups to 7.1 log2, 6.8 log2 and 6.4 log2 at fourth week post vaccination, respectively. The antibody titer against Salmonella Enteritidis was 552 for the prepared combined Salmonella Enteritidis and Newcastle disease, followed by the prepared monovalent Salmonella Enteritidis (477) at first week post vaccination; the antibody titer obtained for the imported vaccine was 477. There was a gradual increase to 1456, 1406 and 1130 at fourth week post vaccination, respectively. Prepared combined vaccines gave the highest protection percentage, followed by prepared monovalent types and finally imported vaccines. Vaccination by the prepared combined Salmonella Enteritidis and Newcastle disease vaccine may be a way to increase the resistance of birds to Salmonella and Newcastle and to decrease the shedding rate(AU)

Este estudio se llevó a cabo para preparar y evaluar la potencia de diferentes formulaciones de vacunas inactivadas que protegen a los pollos contra Salmonella Enteritidis y el virus de la enfermedad de Newcastle utilizando Montanide como adyuvante. Se evaluó la protección y la respuesta inmune humoral de las vacunas preparadas contra Salmonella Enteritidis y el virus de la enfermedad de Newcastle y se comparó con la vacuna importada. En este estudio se prepararon diferentes fórmulas de vacunas contra Salmonella Enteritidis y la enfermedad de Newcastle y se compararon con la importada midiendo el título de anticuerpos contra el virus de la enfermedad de Newcastle mediante la prueba de inhibición de la hemaglutinación y el título de anticuerpos contra Salmonella Enteritidis mediante ELISA. Por otra parte, se registraron los porcentajes de protección contra la enfermedad de Newcastle y Salmonella Enteritidis para determinar la fórmula más eficaz. El mayor nivel de anticuerpos inhibidores de la hemaglutinación contra el virus de la enfermedad de Newcastle, en la primera semana, se registró con la vacuna combinada preparada contra la enfermedad de Newcastle y Salmonella Enteritidis (4,2 log2), seguida de la vacuna monovalente preparada contra la enfermedad de Newcastle (3,4 log2); el menor nivel de anticuerpos (3,1 log2) se obtuvo con la vacuna importada. Se observó un aumento gradual en todos los grupos hasta alcanzar 7,1 log2, 6,8 log2 y 6,4 log2 en la cuarta semana tras la vacunación, respectivamente. El título de anticuerpos contra Salmonella Enteritidis fue de 552 para la vacuna combinada preparada contra la Salmonella Enteritidis y enfermedad de Newcastle, seguida por la vacuna monovalente preparada contra Salmonella Enteritidis (477) en la primera semana después de la vacunación; el título de anticuerpos obtenido con la vacuna importada fue de 477. Hubo un aumento gradual hasta 1456, 1406 y 1130 en la cuarta semana después de la vacunación, respectivamente. Las vacunas combinadas preparadas dieron el mayor porcentaje de protección, seguidas por los tipos monovalentes preparados y, por último, por las vacunas importadas. La vacunación con la vacuna combinada preparada contra la Salmonella Enteritidis y la enfermedad de Newcastle puede ser una forma de aumentar la resistencia de las aves a la Salmonella y Newcastle y de disminuir la tasa de excreción(AU)

Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

BACKGROUND: The epidemiology of the pandemic A(H1N1) virus has been changing as population immunity continues to co-evolve with the virus. The impact of genetic changes in the virus on human's susceptibility is an outstanding important question in vaccine design. In a community-based study, we aim to (1) determine the genetic characteristics of 2009-2015 pandemic H1N1 viruses, (2) assess antibody response following natural infections and (3) assess the correlation of A/California/07/09 antibody titers to protection in the 2013 and 2015 epidemics. METHODS: In a household transmission study, serum specimens from 253 individuals in Managua, Nicaragua were analyzed. Combined nose and throat swabs were collected to detect RT-PCR confirmed influenza infection and virus sequencing. Hemagglutination inhibition assays were performed and the protective titer for circulating H1N1pdm was determined. RESULTS: Clade 6B pandemic H1N1 viruses predominated in Nicaragua during the 2013 and 2015 seasons. Our household transmission study detected a household secondary attack rate of 17% in 2013 and 33% in 2015. Infected individuals, including vaccinees, showed an apparent antibody response to A/California/07/09. Baseline titers of A/California/07/09 antibodies were found to associate with protection in both seasons. A titer of ≥1:40 correlated to a 44% protection in children, a 29% protection in adults 15-49years old and a 51% protection in adults 50-85years old. CONCLUSION: In 2013 and 2015, antibody titers to A/California/07/09 associated with an infection risk reduction amongst exposed household contacts. This is consistent with a detectable vaccine effectiveness reported in a number of studies. Genetic changes in clade 6B viruses might have led to a reduced immunity in some whereas others might have been less affected. The use of human serologic data is important in virus characterization and if performed in a timely manner, could assist in vaccine strain selection.

A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.

BACKGROUND: The 2009 H1N1 influenza pandemic initially affected Mexico from April 2009 to July 2010. By August 2010, a fourth of the population had received the monovalent vaccine against the pandemic virus (A(H1N1)pdm09). To assess the proportion of the Mexican population who remained potentially susceptible to infection throughout the summer of 2010, we estimated the population seroprevalence to A(H1N1)pdm09 in a serosurvey of blood donors. METHODS: We evaluated baseline cross-reactivity to the pandemic strain and set the threshold for seropositivity using pre-pandemic (2005-2008) stored serum samples and sera from confirmed A(H1N1)pdm09 infected individuals. Between June and September 2010, a convenience sample serosurvey of adult blood donors, children, and adolescents was conducted in six states of Mexico. Sera were tested by the microneutralization (MN) and hemagglutination inhibition (HI) assays, and regarded seropositive if antibody titers were equal or exceeded 1:40 for MN and 1:20 for HI. Age-standardized seroprevalence were calculated using the 2010 National Census population. RESULTS: Sera from 1,484 individuals were analyzed; 1,363 (92%) were blood donors, and 121 (8%) children or adolescents aged ≤19 years. Mean age (standard deviation) was 31.4 (11.5) years, and 276 (19%) were women. A total of 516 (35%) participants declared history of influenza vaccination after April 2009. The age-standardized seroprevalence to A(H1N1)pdm09 was 48% by the MN and 41% by the HI assays, respectively. The youngest quintile, aged 1 to 22 years, had the highest the seroprevalence; 61% (95% confidence interval [CI]: 56, 66%) for MN, and 56% (95% CI: 51, 62%) for HI. CONCLUSIONS: Despite high transmission of A(H1N1)pdm09 observed immediately after its emergence and extensive vaccination, over a half of the Mexican population remained potentially susceptible to A(H1N1)pdm09 infection. Subsequent influenza seasons with high transmission of A(H1N1)pdm09, as 2011-2012 and 2013-2014, are compatible with these findings.

Ocorrência de infecção por parvovírus suíno e gastrenterite transmissível em suínos, criados de forma extensiva, em Goiás / Occurrence of porcine parvoviral infection and transmissible gastroenteritis virus infection in swine from extensive raising systems in the state of Goiás, Brazil

The serological status of porcine parvovirus (PPV) infection and transmissible gastroenteritis virus (TGEV) infection were determined in swine from extensive raising systems in the state of Goiás, Brazil. Ninety-seven serum samples were collected from animals in 12 extensive farms distributed in six cities located nearby Goiânia, GO, and 74 samples were collected from animals in a slaughterhouse in Goiânia, GO. For the PPV-specific antibody detection, the hemaglutination inhibition test (HI) was used; and for TGE antibody detection, the serum neutralization test was performed. Results showed that 25 out of the total 171 (14.4%) analyzed sera were positive for PPV antibodies, and the HI titers varied between 256 to 4,096. None of the 136 serum samples analyzed for TGEV was positive. This is probably the first study that detected PPV and TGEV-specific antibodies in swine herd in the state of Goiás. Data suggest that PPV but not TGEV circulated between and among this population of swine in that state.(AU)

Ocorrência de infecção por parvovírus suíno e gastrenterite transmissível em suínos, criados de forma extensiva, em Goiás / Occurrence of porcine parvoviral infection and transmissible gastroenteritis virus infection in swine from extensive raising systems in the state of Goiás, Brazil

The serological status of porcine parvovirus (PPV) infection and transmissible gastroenteritis virus (TGEV) infection were determined in swine from extensive raising systems in the state of Goiás, Brazil. Ninety-seven serum samples were collected from animals in 12 extensive farms distributed in six cities located nearby Goiânia, GO, and 74 samples were collected from animals in a slaughterhouse in Goiânia, GO. For the PPV-specific antibody detection, the hemaglutination inhibition test (HI) was used; and for TGE antibody detection, the serum neutralization test was performed. Results showed that 25 out of the total 171 (14.4%) analyzed sera were positive for PPV antibodies, and the HI titers varied between 256 to 4,096. None of the 136 serum samples analyzed for TGEV was positive. This is probably the first study that detected PPV and TGEV-specific antibodies in swine herd in the state of Goiás. Data suggest that PPV but not TGEV circulated between and among this population of swine in that state.

Antigenic characterization of canine parvovirus isolates from Brazil using specific monoclonal antibodies / Caracterização antigênica de isolados de parvovirus canino do Brasil utilizando monoclonais específicos

Canine parvovirus (CPV) is an emerged pathogen in dogs, first isolated in 1978 in the USA. The original 1978 strain was designated CPV type 2 (CPV-2). However, analysis of CPV isolates in the USA by restriction enzymes and monoclonal antibodies have shown that around the year 1979 a CPV variant strain, designated CPV type 2a (CPV-2a), became widespread. Subsequently, a new antigenic strain, designated CPV type 2b (CPV-2b), was also observed by analysis of CPV isolates from various parts of the world, although the proportion of each strains was different between countries. In this study, the Haemagglutination Inhibition (HI) test with a panel of monoclonal antibodies was used to type canine parvovirus strains in 29 fecal samples collected from symptomatic dogs from 1980 to 1986 and from 1990 to 1995. The results showed a strong predominance of the antigenic type 2a indicating that the CPV epizooty in Brazil followed the same pattern observed in European and Asian countries.

O Parvovírus Canino (CPV) é um patógeno emergente em cães, isolado pela primeira vez em 1978, nos Estados Unidos. A amostra original de 1978 foi designada CPV tipo 2 (CPV-2). Entretanto, análises de isolados de CPV dos Estados Unidos, por enzimas de restrição e anticorpos monoclonais demonstraram que cerca de 1979, uma amostra variante, designada CPV tipo 2a (CPV-2a) tornou-se prevalente. Subseqüentemente, uma nova amostra antigênica, designada CPV tipo 2b (CPV-2b) também foi observada por análises de isolados de CPV de várias partes do mundo, embora a proporção fosse diferente entre os países. Nesse estudo, foi utilizado o teste de Inibição da Hemaglutinação (HI) com um painel de anticorpos monoclonais para a tipagem de 29 amostras fecais de parvovirus canino, coletadas de cães sintomáticos de 1980 a 1986 e de 1990 a 1995. Os resultados indicaram uma forte predominância do tipo antigênico 2a indicando que a epizootia de CPV no Brasil seguiu o mesmo padrão observados na Europa e países Asiáticos.

Antigenic characterization of canine parvovirus isolates from Brazil using specific monoclonal antibodies / Caracterização antigênica de isolados de parvovirus canino do Brasil utilizando monoclonais específicos

Canine parvovirus (CPV) is an emerged pathogen in dogs, first isolated in 1978 in the USA. The original 1978 strain was designated CPV type 2 (CPV-2). However, analysis of CPV isolates in the USA by restriction enzymes and monoclonal antibodies have shown that around the year 1979 a CPV variant strain, designated CPV type 2a (CPV-2a), became widespread. Subsequently, a new antigenic strain, designated CPV type 2b (CPV-2b), was also observed by analysis of CPV isolates from various parts of the world, although the proportion of each strains was different between countries. In this study, the Haemagglutination Inhibition (HI) test with a panel of monoclonal antibodies was used to type canine parvovirus strains in 29 fecal samples collected from symptomatic dogs from 1980 to 1986 and from 1990 to 1995. The results showed a strong predominance of the antigenic type 2a indicating that the CPV epizooty in Brazil followed the same pattern observed in European and Asian countries.(AU)

O Parvovírus Canino (CPV) é um patógeno emergente em cães, isolado pela primeira vez em 1978, nos Estados Unidos. A amostra original de 1978 foi designada CPV tipo 2 (CPV-2). Entretanto, análises de isolados de CPV dos Estados Unidos, por enzimas de restrição e anticorpos monoclonais demonstraram que cerca de 1979, uma amostra variante, designada CPV tipo 2a (CPV-2a) tornou-se prevalente. Subseqüentemente, uma nova amostra antigênica, designada CPV tipo 2b (CPV-2b) também foi observada por análises de isolados de CPV de várias partes do mundo, embora a proporção fosse diferente entre os países. Nesse estudo, foi utilizado o teste de Inibição da Hemaglutinação (HI) com um painel de anticorpos monoclonais para a tipagem de 29 amostras fecais de parvovirus canino, coletadas de cães sintomáticos de 1980 a 1986 e de 1990 a 1995. Os resultados indicaram uma forte predominância do tipo antigênico 2a indicando que a epizootia de CPV no Brasil seguiu o mesmo padrão observados na Europa e países Asiáticos.(AU)

Ascaris lumbricoides: epitopes del Sistema P por método de cinética de la hemaglutinación / Ascaris lumbricoides: P system epithopes by haemogglutination kinetics method

Experiencias previas demostraron epitopes P1 en Ascaris lumbricoides por inhibición de la aglutinación. La cinética de la hemaglutinación aplica la extinción óptica relativa producida por un haz de luz trasmitido a través de una suspensión de pequeñas partículas, y permite obtener una estimación paramétrica de la tasa de hemaglutinación. El objetivo de este trabajo fue utilizar este método para demostrar la presencia de epitopes del Sistema P en extractos de A. lumbricoides. La técnica de inhibición de la aglutinación permitió seleccionar 10 extractos: 3 con y 7 sin epitopes P1. Se registró la cinética de la reacción Control: anti- P1- eritrocitos - P1 y la cinética de la misma reacción, previo contacto del anticuerpo con el extracto. Se calcularon y se compararon los valores de ³ EOR % (variación en el porcentaje de extinción óptica relativa) para ambas reacciones. Los resultados evidenciaron la presencia de epitopes P1, que no habían sido detectados por inhibición de la aglutinación, en 3 extractos. Para los extractos restantes, hubo coincidencia entre los resultados obtenidos por los dos métodos. La cinética de la hemaglutinación es sencilla, rápida y fácilmente adaptable para las experiencias en que se necesite evaluar una reacción antígeno-anticuerpo a través de la hemaglutinación.

Summary Previous experiences have demonstrated P1 epithopes in Ascaris lumbricoides by inhibition agglutination. Haemogglutination kinetics applies the relative optical extinction produced on a light beam transmitted through a suspension of small particles, giving a parametric estimate of the haemagglutination rate.The aim was to use this method for the demonstration of P System epithopes presence in A. lumbricoides extracts. inhibition agglutination test enabled the selection of 10 extracts: 3 with and 7 without P1 epithopes. Kinetics of anti- P1 - P1 erythrocyte control reaction and kinectics of the same reaction with a previous contact between antibody and extract were registered. ³ EOR % values (relative optical extinction variation) for both reactions were calculated and compared between themselves. The results proved P1 epithopes presence in 3 extracts, which had not been detected by inhibition agglutination. The results coincided for the remaining extracts by both methods. Haemogglutination kinetics is simple and fast and it is easily adapted for experiences in which the investigator needs to assess the antibody-antigen reaction by haemogglutination.

Utility of the Determine Syphilis TP rapid test in commercial sex venues in Peru.

OBJECTIVES: This study sought to evaluate the utility of the Determine Syphilis TP test performed in Peruvian commercial sex venues for the detection of active syphilis; and determine the feasibility of integrating rapid syphilis testing for female sex workers (FSW) into existing health outreach services. METHODS: We tested 3586 female sex workers for syphilis by Determine in the field using whole blood fingerstick, and by rapid plasma reagin (RPR) and Treponema pallidum haemagglutination assay (TPHA) in a central laboratory in Lima using sera. RESULTS: 97.4% of the FSW offered rapid syphilis testing participated; and among those who tested positive, 87% visited the local health centre for treatment. More than twice as many specimens were RPR reactive using serum in Lima (5.7%) than tested positive by whole blood Determine in the field (2.8%), and although most were confirmed by TPHA, only a small proportion (0.7%) were RPR reactive at >or=1:8 dilutions, and likely indicating active syphilis. Sensitivity, specificity and positive predictive value of the Determine Syphilis TP test in whole blood when compared to serum RPR reactivity at any dilution confirmed by TPHA as the gold standard were 39.3%, 99.2% and 71.4%, respectively. Sensitivity improved to 64.0% when using serum RPR >or=1:8 confirmed by TPHA. Invalid tests were rare (0.3%). CONCLUSIONS: Rapid syphilis testing in sex work venues proved feasible, but Determine using whole blood obtained by fingerstick was substantially less sensitive than reported in previous laboratory-based studies using serum. Although easy to perform in outreach venues, the utility of this rapid syphilis test was relatively low in settings where a large proportion of the targeted population has been previously tested and treated.

Genomic typing of canine parvovirus circulating in the State of Rio de Janeiro, Brazil from 1995 to 2001 using polymerase chain reaction assay.

In this study, the genomic types of canine parvovirus (CPV) circulating in the State of Rio de Janeiro, Brazil, from 1995 to 2001, were investigated using the polymerase chain reaction assay (PCR). A total of 78 faecal samples from gastroenteritic puppies, confirmed as positive for canine parvovirus by haemagglutination/haemagglutination inhibition tests or virus isolation in cell culture (MDCK), were examined. The viral DNA was extracted from faecal samples using a combination of phenol- chloroform and silica-guanidine thiocyanate methods. PCR was carried out with differential pairs of primers to distinguish the old (CPV-2) and new types of virus (CPv-2a or CPV-2b). Specific amplicons were observed for all samples using the primer pair P2ab, which detects CPV-2a and CPV-2b. Seventy-six from a total of 78 samples (97%) were considered as CPV-2b because of their reaction with the primer pair P2b. Thirty samples (30/78) were from previously vaccinated puppies and in 15 of them the enteritis symptoms began from 1 to 12 days after vaccination. PCR confirmed the infection by wild virus (CPV-2b) in 5 of these 15 puppies who had received old-type vaccines. Our results show that CPV-2b was the prevalent type circulating in the State of Rio de Janeiro from 1995 to 2001.

Presencia de anticuerpos a sarampión, rubéola y parotiditis en una población cubana de 7 meses a 23 años / Presence of measles, rubella and parotiditis antibodies in a Cuban population aged 7-23

Se creó un programa a partir de 1988 por las autoridades de salud en Cuba, en el cual se trazó como meta eliminar el sarampión, la rubéola y la parotiditis. Sus bases fundamentales fueron alcanzar coberturas de vacunación superiores a 95 por ciento con la vacuna triple viral (sarampión, rubéola y parotiditis), implantar un sólido sistema de vigilancia seroepidemiológica y lograr medidas de control de foco, con lo cual cesaría la transmisión del virus salvaje productor de estas entidades. Con el fin de conocer el estado inmune de la población a más de 10 años de iniciarse la vacunación con la triple viral, se realizó una encuesta seroepidemiológica a una muestra representativa de la población cubana entre 7 meses y 23 años. Se estudió un total de 1 593 muestras mediante la prueba de inhibición de la hemaglutinación. La prevalencia de anticuerpos detectada fue de 86,75 por ciento para sarampión, 64,72 por ciento para rubéola y 86 por ciento para parotiditis. La inmunidad a los virus del sarampión y rubéola fue menor en el grupo de 6 a 10 años y en el caso de la parotiditis en los niños entre 2 y 5 años. Se sugirió incluir en el programa nacional de vacunación, una segunda dosis de la vacuna triple viral en los niños de 6 años o más, para eliminar la circulación de estos agentes infecciosos en la población(AU)

Dengue diagnosis, advances and challenges.

Dengue diagnosis was one of the topics discussed at the symposium 'The Global Threat of Dengue - Desperately Seeking Solutions' organized during the 10th International Congress of Infectious Diseases held in Singapore in 2002. In this paper, a review is presented focusing on the main advances, problems and challenges of dengue diagnosis.IgM capture ELISA, virus isolation in mosquito cell lines and live mosquitoes, dengue specific monoclonal antibodies and PCR have all represented major advances in dengue diagnosis. However, an appropriate rapid, early and accessible diagnostic method useful both for epidemiological surveillance and clinical diagnosis is still needed. Also, tools that suggest a prognosis allowing for better management are also needed. Finally, laboratory infrastructure, technical expertise and research capacity must be improved in endemic countries in order to positively influence dengue surveillance, clinical case management and the development of new approaches to dengue control.

Incidência do vírus influenza A e B na populaçäo de Maceió-AL, Brasil / Incidence of influenza A and B viruses among the population of Maceió-AL, Brazil

Vírus respiratórios säo responsáveis por uma grande percentagem das doenças na populaçäo humana. Um estudo soro-epidemiológico foi feito para determinar a prevalência de anticorpos para as cepas do subtipo A: A/ Taiwan/1/86 (H1N1), A/Shangdong/9/93 (H3N2), A/Shanghai/11/87 (H3N2) e A/Wuhan/359/95 (H3N2) foi 189, 223,230 e 103 amostras, respectivamente. E para o subtipo B: B/Panamá/45/20, B/Guangdong/8/93 e B/Beijing/184/93 foi 191, 126 e 103 amostras, respectivamente. Os soros foram obtidos no período de 1996/1997, de pacientes internos e externos do Hospital Universitário (HU) da Universidade Federal de Alagoas de diferentes faixas etárias e de ambos os sexos. A técnica utilizada para pesquisar anticorpos específicos foi a de Inibiçäo da Hemaglutinaçäo (HI). A prevalência de anticorpos para A/Taiwan/1/86 (H1N1), A/Shaigdong/9/93 (H3N2), A/Shangai/11/87 (H3N2) e A/Wuhan/359/95 (H3N2) foi 94 porcento, 93 porcento, 81 porcento e 78 porcento respectivamente e o B/Panamá/45/20, B/Guangdong/8/93 e B/Beijing/184/93 foi 52 porcento, 23 porcento e 53 porcento respectivamente. A presença de marcadores sorológicos do Vírus Influenza A e B em nossa populaçäo evidenciada pela primeira vez e mostrou ser em índices elevados, indicando uma ampla disseminaçäo desses subtipos

Antigenic relatedness of selected flaviviruses: study with homologous and heterologous immune mouse ascitic fluids

A relacao antigenica de 9 Flavivirus, febre amarela (YF), Wesselsbron (WSL), Uganda S (UGS), Potiskum (POT), West Nile (WN), Banzi (BAN), Zika (ZK), Dengue tipo 1 (DEN-1) e Dengue tipo 2 (DEN-2), foi avaliada por reacao de inibicao da hemaglutinacao cruzada (cross-HI) e reacao de fixacao do complemento cruzada (Cross-CF) entre cada um dos virus e seu fluido ascitico homologo em camundongos. Medias de titulos foram calculadas usando os titulos heterologos e homologos. Reacoes cruzadas CF revelaram maiores variacoes antigenicas entre virus do que reacoes cruzadas HI. Nao houve variacao antigenica significativa entre virus WSL, POT e YF usando cada um dos metodos. Todavia, diferencas definidas da antigenicidade foram observadas entre eles e os virus UGS, BAN e ZK. Nao existiram diferencas significativas entre UGS, BANe ZK ou entre DEN-1 e DEN-2. A relacao sorologica entre Flavivirus e importante para se estabelecer o diagnostico e a epidemiologia destas infeccoes na Africa

Inmunovaloración de anticuerpos IgM en muestras sospechosas de sarampión clínicamente / Immunoevaluation of IgM antibodies in samples clinically suspicious of measles

Se realiza el estudio de 60 sueros pareados sospechosos de Sarampión clínicamente llegados al Laboratorio Diagnóstico del Instituto de Medicina Tropical "Pedro Kourí" entre enero y mayo de 1996, procedentes de la vigilancia seroepidemiológica de la vacuna triple viral (sarampion, rubéola y parotiditis), a los cuales se les realizó la detección de anticuerpos hemaglutinantes a sarampión y rubéola, así como de IgM, con el estuche diagnóstico Clark Laboratories INC Measles IgM ELISA. Los casos positivos se confirmaron por las técnicas de inmunofluorescencia indirecta-IgM y neutralización. Se obtuvieron por inhibición de la hemaglutinación, 3 casos positivos a sarampión y rubéola, los cuales negativos a IgM de sarampión y a los que se les determinaron anticuerpos a Epstein Barr, Citomegalovirus y al virus herpes simple mediante inmunifluorescencia indirecta (IFI) la capacidad de estos virus de inducir respuesta policlonal. Por medio del ELISA IgM Clark se detectaron 6 casos positivos los cuales resultaron negativos por IFI (AU)

ELISA de inhibición. Su utilidad para clasificar un caso de dengue / Inhibition ELISA. Its usefulness for classifying a case of dengue

Para la clasificación de casos de dengue la OMS/OPS incluye a la inhibición de la hemaglutinación como una de las técnicas serológicas para estos fines y se acepta también la posibilidad de utilizar el ELISA con un título equivalente al establecido por la IH. En este trabajo se presenta la utilidad del ELISA de inhibición para la clasificación de caso probable, confirmado y tipo de infección (primaria y secundaria) de dengue(AU)

ELISA de inhibición. Su utilidad para clasificar un caso de dengue / Inhibition ELISA. Its usefulness for classifying a case of dengue

Para la clasificación de casos de dengue la OMS/OPS incluye a la inhibición de la hemaglutinación como una de las técnicas serológicas para estos fines y se acepta también la posibilidad de utilizar el ELISA con un título equivalente al establecido por la IH. En este trabajo se presenta la utilidad del ELISA de inhibición para la clasificación de caso probable, confirmado y tipo de infección (primaria y secundaria) de dengue

Plague surveillance in Brazil: 1983-1992

A peste, infeccao pela Yersinia pestis, se mantem no Brasil, em varios focos naturais, disseminados na area rural, dos Estados do Ceara, Paraiba, Pernambuco, Piaui, Rio Grande do Norte, Alagoas, Bahia, Minas Gerais e Rio de Janeiro. Desde de 1983, o teste de hemaglutinacao passiva para anticorpos contra a fracao antigenica "F1A" de Y. pestis, vem sendo empregado ininterruptamente na vigilancia da peste nos focos brasileiros. A especificidade do PHA e controlada pelo teste de inibicao da aglutinacao. No periodo de 1983 a 1992 foram examinadas 220.769 amostras de soro, sendo 2.856 de origem humana, 49.848 de roedores pertencentes a 24 especies e de 2 especies de pequenos carnivoros selvagens (marsupiais), 122.890 soros de caes e 45.175 de gatos. Anticorpos especificos foram encontrados em 92 (3,22 por cento) dos soros humanos; 143 (0,29 por cento) soros de roedores de 8 especies e das duas especies de marsupiais, 1.105 (0,90 por cento) soros de caes e 290 (0,64 por cento) soros de gatos...

Secondary dengue infection in schoolchildren in a dengue endemic area in the state of Rio de Janeiro, Brazil

Apos um periodo de epidemias sequenciais pelos virus dengue tipo 1 e 2 (DEN-1 e DEN-2), foi realizado um estudo soroepidemiologico e uma amostra de escolares da rede publica de ensino do municipio de Niteroi; 450 amostras de sangue foram obtidas atraves de puncao da polpa digital, coletadas sobre discos de papel de filtro e testadas para a deteccao de anticorpos inibidores da hemaglutinacao (IHA) para DEN-1 e DEN-2. Das amostras testadas, 66,0 por cento (297/450) apresentaram titulos de anticorpos IHA e as medias geometricas dos titulos de anticorpos foram de 1/182 e 1/71, para DEN-1 e DEN-2, respectivamente. Cerca de 61,0 por cento (181/297) daqueles com anticorpos IHA tiveram infeccao secundaria. Destes, 75 por cento (135/181) tinham idade igual a ou menor do que 15 anos...

Relación entre cepas de enterobacterias manosa resistentes y presencia de células centelleantes en el sedimento urinario / Relation among enterobacteriaceae mannosa resistant isolates and glitter cells in the urinary sediments

La presencia de células con características especiales denominadas células centelleantes, en el sedimento urinario provenientes de infecciones urinarias producidas por cepas de enterobacterias que expresan fimbrias Pap, fue evaluada en este estudio. En 143 cepas de enterobacterias, la capacidad de adhesión fue analizada aglutinación de glóbulos rojos humanos grupo A suspendidos en buffer fosfato (PBS), para ver hemoaglutinación (HA), y con el agregado de D-manosa al 1 por ciento para detectar hemoaglutinación manosa-sensible (HAMS) o manosa resistente (HAMR). Escherichia coli presentó una diferencia significativa en el número de cepas que expresan fimbrias manosa resistente (MR):56 y las que expresan fimbrias manosa sensibles (MS):25. Las especies MR, fueron enfrentadas con glóbulos rojos humanos grupo P y eritrocitos de cerdo, utilizando como inhibidor de la hemoaglutinación el digalactósido (1-4) -ß-D galactopiranósido. No se estableció una diferencia notable en el número de cepas con fimbrias MR, que presentaron capacidad hemoaglutinante, frente a las dos especies de eritrocitos. Pero fue comparativamente mayor, el número de cepas con fimbrias Pap que aglutinaron glóbulos rojos humanos grupo P. La relación presencia de células centelleantes en el sedimento urinario y cepas de enterobacterias que expresan fimbrias MR, como agente etiológico del proceso infeccioso, fue significativamente mayor que la establecida por cepas con fimbrias MS (AU)